Themis Medicare Ltd. (THEMISMED): Themis Medicare Share Price rises 8.81% to Rs 129.65; market cap at Rs 1,112.57 crore
- August 26, 2026
- Posted by: Harsh Piplani
- Category: News
Themis Medicare Share Price is in focus today after Themis Medicare Ltd. rose 8.81% to Rs 129.65 from the previous close of Rs 119.15. The stock added Rs 10.50 during the session, opened at Rs 120.10, touched a day high of Rs 132.50 and a day low of Rs 119.55. The company’s market capitalisation stands at Rs 1,112.57 crore, placing the move in a clearly defined market context.
The supplied data confirms a same-day price rise, but it does not establish a company-specific catalyst. That makes Themis Medicare Stock News relevant mainly as a verified price-event update rather than a cause-led story. For readers tracking Themis Medicare Share Price Today, the key points are the size of the move, the session range and the valuation backdrop. Univest is presenting this as an event-led stock analysis, while the broader question for investors is whether the current price aligns with the company’s financial and sector profile.
Themis Medicare Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 129.65 |
| Previous Close | Rs 119.15 |
| Today's Move | Rs 10.5 (+8.81%) |
| Open | Rs 120.1 |
| High | Rs 132.5 |
| Low | Rs 119.55 |
| Turnover | Rs 0.42 crore |
| Market Capitalisation | Rs 1,112.57 crore |
| Market Cap Category | Small Cap |
Themis Medicare Ltd. (THEMISMED) rose to Rs 129.65 from the previous close of Rs 119.15, a move of Rs 10.5 or 8.81%. The stock opened at Rs 120.1, reached a high of Rs 132.5, recorded a low of Rs 119.55.
Themis Medicare Share Price Today reflects a firm session in which the stock moved from Rs 119.15 to Rs 129.65, a gain of 8.81%. The day’s range of Rs 119.55 to Rs 132.50 shows that the stock traded through a fairly wide band during the session, while turnover stood at Rs 0.42 crore. The current level is above the previous close and close to the upper end of the day’s range, which makes the price rise the central event in Themis Medicare Share News today. Univest is tracking this as a clean price-action move supported by verified numbers, not by an unconfirmed trigger.
Themis Medicare Ltd. (THEMISMED) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,112.57 crore |
| P/E Ratio | 27.45x |
| P/B Ratio | 2.83x |
| ROE | 7.65% |
| ROCE | 10.37% |
| EPS | Rs 4.34 |
| Book Value Per Share | Rs 42.13 |
| Dividend Yield | 0.42% |
Themis Medicare Ltd. (THEMISMED) fundamental metrics show P/E 27.45x, P/B 2.83x, ROE 7.65%, ROCE 10.37%. These figures provide context only and are not a buy or sell signal.
Themis Medicare Ltd. has a market capitalisation of Rs 1112.57 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 27.45x, P/B at 2.83x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 7.65% and ROCE of 10.37%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 4.34, book value per share of Rs 42.13, dividend yield of 0.42%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.52x, median ROE of 11.82%, median ROCE of 13.88%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 27.45x |
| Benchmark Median P/E | 30.52x |
| Benchmark Average P/E | 46.79x |
| Benchmark P/E Range | 2.94x to 717.81x |
| Company P/B Ratio | 2.83x |
| Benchmark Median P/B | 2.71x |
| Company ROE | 7.65% |
| Benchmark Median ROE | 11.82% |
| Company ROCE | 10.37% |
| Benchmark Median ROCE | 13.88% |
| Company Market Capitalisation | Rs 1,112.57 crore |
| Benchmark Median Market Cap | Rs 613.53 crore |
Themis Medicare Ltd. (THEMISMED) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Themis Medicare Ltd. (THEMISMED) has a P/E ratio of 27.45x, which is below the benchmark median of 30.52x, a difference of -10.06%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Themis Medicare Ltd. (THEMISMED) has a ROE of 7.65%, which is below the benchmark median of 11.82%, a difference of -35.28%. Themis Medicare Ltd. (THEMISMED) has a ROCE of 10.37%, which is below the benchmark median of 13.88%, a difference of -25.29%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,58,248.99 | 38.03 | 5.32 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,25,648.29 | 78.78 | 13.05 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,84,891.11 | 85.81 | 20.85 | 26.76 | 19.27 |
| Cipla Ltd. | CIPLA | 1,15,926.93 | 34.03 | 3.26 | 11.83 | 16 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,09,825.17 | 24.98 | 4.18 | 19.69 | 21.39 |
Themis Medicare Ltd. (THEMISMED) has a P/E ratio of 27.45x compared with the displayed peer median of 38.03x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 7.65% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 10.37% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Themis Medicare Ltd. (THEMISMED) has a market capitalisation of Rs 1,112.57 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Themis Medicare
- Themis Medicare Share Price rose 8.81% today to Rs 129.65.
- The session moved from Rs 119.15 to a high of Rs 132.50.
- Market capitalisation stands at Rs 1,112.57 crore.
- P/E is 27.45, P/B is 2.83, ROE is 7.65% and ROCE is 10.37%.
- In the same industry benchmark, P/E is below the median of 30.52 and ROE and ROCE are below the benchmark medians.
About Themis Medicare
Themis Medicare Ltd. operates in the Pharmaceuticals & Drugs industry under the Healthcare sector. The company’s share price and financial profile are now being tracked by investors who follow the Indian stock market and sector updates in pharmaceuticals. Based on the supplied company data, the business belongs to a sector where comparisons on earnings, returns and valuation are important for reading stock performance.
Themis Medicare Stock News today is therefore best understood as a combination of price action and company fundamentals. The stock’s current market cap of Rs 1,112.57 crore, EPS of Rs 4.34, book value of Rs 42.13 and dividend yield of 0.42% give a clear snapshot of the company’s reported financial context. Univest presents this alongside industry and peer comparison so readers can place the share price move within the broader market update.
Track Themis Medicare Share Price on Univest
Use Themis Medicare Ltd. (THEMISMED) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
You can track Themis Medicare Share Price on Univest for live share price updates, share price rise coverage, fundamental ratios, shareholding pattern, market cap, 52-week levels and company insights. Univest also helps readers compare Themis Medicare Stock Analysis with sector benchmarks and peer names in Healthcare.
For investors following Themis Medicare Company News, Univest keeps the focus on verified stock data rather than speculation. That makes it easier to follow Themis Medicare Share Price Today, Themis Medicare Stock Gaining Today and Themis Medicare Latest News in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Themis Medicare Share Price rising today?
Ans. The supplied data confirms an 8.81% same-day rise in Themis Medicare Share Price to Rs 129.65. It does not establish a company-specific catalyst, so the move should be read as verified price action only.
What is Themis Medicare Share Price today?
Ans. Themis Medicare Share Price today is Rs 129.65. It is up from the previous close of Rs 119.15, with a day gain of Rs 10.50 and a market cap of Rs 1,112.57 crore.
What is the market cap of Themis Medicare?
Ans. Themis Medicare has a market capitalisation of Rs 1,112.57 crore. That figure places the company above the benchmark median market cap in its industry snapshot, though well below the average.
How is Themis Medicare valued on P/E and P/B?
Ans. Themis Medicare has a P/E ratio of 27.45 and a P/B ratio of 2.83. In the same-industry benchmark, its P/E is below the median, while its P/B is slightly above the median.
What do ROE, ROCE and EPS show for Themis Medicare?
Ans. Themis Medicare reports ROE of 7.65%, ROCE of 10.37% and EPS of Rs 4.34. These figures help readers assess profitability, capital returns and earnings per share alongside the share price.
How does Themis Medicare compare with healthcare peers?
Ans. Themis Medicare’s valuation and return ratios sit below several supplied peers such as Lupin, Zydus Lifesciences and Torrent Pharmaceuticals. It remains in the same healthcare and pharmaceuticals industry set for comparison.
Should investors track Themis Medicare Share Price on Univest?
Ans. Yes. Univest tracks Themis Medicare Share Price, market cap, valuation ratios, peer comparison and sector context in one place. That gives readers a factual way to follow Themis Medicare Stock News and updates.
